CORE LABORATORIES N V Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q4 2010 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Core Laboratories N V quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q4 2010 to Q4 2022.
  • Core Laboratories N V Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending December 31, 2022 was $13.1M, a 23.3% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $13.1M +$2.48M +23.3% Dec 31, 2022 10-K 2023-02-10
Q4 2021 $10.6M -$3.27M -23.5% Dec 31, 2021 10-K 2023-02-10
Q4 2020 $13.9M +$6.68M +92.7% Dec 31, 2020 10-K 2022-02-10
Q4 2019 $7.21M +$909K +14.4% Dec 31, 2019 10-K 2021-02-08
Q4 2018 $6.3M -$1.68M -21% Dec 31, 2018 10-K 2020-02-10
Q4 2017 $7.98M -$1.91M -19.3% Dec 31, 2017 10-K 2019-02-11
Q4 2016 $9.89M +$1.84M +22.9% Dec 31, 2016 10-K 2018-02-12
Q4 2015 $8.05M +$1.71M +26.9% Dec 31, 2015 10-K 2017-02-10
Q4 2014 $6.34M +$958K +17.8% Dec 31, 2014 10-K 2016-02-12
Q4 2013 $5.38M -$484K -8.25% Dec 31, 2013 10-K 2015-02-17
Q4 2012 $5.87M -$1.28M -17.9% Dec 31, 2012 10-K 2014-02-13
Q4 2011 $7.14M -$2.38M -25% Dec 31, 2011 10-K 2013-02-19
Q4 2010 $9.52M Dec 31, 2010 10-K 2012-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.